Dr. Gabriele Bergers is a Professor of Oncology at the University of Leuven and a group leader at the VIB-Center for Cancer Biology in Leuven since 2016. She is also a Professor in the Department of Neurological Surgery, and a PI in the Brain Tumor Research Center (BTRC) at the Helen Diller Family Comprehensive Cancer Center at the University of California, San Francisco for 19 years. She has made seminal discoveries about tumor niches regarding both the interactions among tumor cells, the vasculature, and inflammatory cell constituents in regulating neovascularization and invasion in various mouse models of brain, breast and pancreatic cancer and in revealing and understanding intrinsic and evasive resistance mechanisms of tumors to antiangiogenic therapy.

Dr. Bergers has received several awards for her research, including the Sidney Kimmel, the Sandler Opportunity, UCSF Breakthrough Biomedical Research and the Judah Folkman award. She has been an External Advisory Board member for various universities and pharmaceutical companies and is currently on the Editorial Board of Science. She has served on the NIH Tumor Microenvironment Study Section since 2006 and was Chair from 2010-12. She is currently a panel member of several grant institutions including CPRIT, ERC, AIRC and CRUK.  Dr. Bergers was the co-director of the TMEN (Tumor Microenvironment) Brain Tumor Center at UCSF , as well as an EAB member at the Max-Planck-Institute for Biomedicine (Vascular Biology focus) in Muenster, Germany.

Follow on Twitter